tsx « AGORACOM Small-cap Investor Relations Blog

Posts Tagged ‘tsx’

Loop Insights $MTRX.ca and ImagineAR $IP.ca $IPNFF Sign MOU To Integrate Artificial Intelligence and Augmented Reality #AR, Creating Real-Time Actionable Data For Brands To Hyper Target Consumers and Sports Fans

Posted by AGORACOM-JC at 7:16 AM on Monday, July 20th, 2020

Announced the signing of an MOU with ImagineAR (CSE: IP); (OTCQB: IPNFF) an Augmented Reality (“AR”) mobile platform
Integration of each company’s respective technologies into a singular platform will deliver personalized promotions and targeted engagement, leading to higher conversions and transaction revenue in the professional sports, entertainment, and retail industries
Both companies are well supported and positioned with Loop recently becoming a member of the Amazon Partner Network and ImagineAR being a Microsoft co-sell Azure partner

VANCOUVER, BC, July 20, 2020 – Loop Insights Inc. (TSXV: MTRX) (the “Company” or “Loop”), a provider of contactless solutions and Artificial Intelligence (“AI”) to drive marketing and real-time consumer insights, is pleased to announce the signing of an MOU with ImagineAR (CSE: IP); (OTCQB: IPNFF) an Augmented Reality (“AR”) mobile platform.

The integration of each company’s respective technologies into a singular platform will deliver personalized promotions and targeted engagement, leading to higher conversions and transaction revenue in the professional sports, entertainment, and retail industries.

Both companies are well supported and positioned with Loop recently becoming a member of the Amazon Partner Network and ImagineAR being a Microsoft co-sell Azure partner. ImagineAR clients include NBA Sacramento Kings, AT&T, Mall of America, and the Basketball Hall of Fame.

LOOP INSIGHTS ENTERING COMMERCIALIZATION WITH TIER-1 CUSTOMERS AND NORTH AMERICAN TELECOM GIANTS

On July 13, 2020, Loop announced the acceleration of conversations and projects with two of Canada’s largest telecommunications companies, as well as, two of the largest network providers in the United States. Moreover, the Company is in advanced discussions with major organizations in the NFL, NHL, NCAA, and a globally renown Casino company.

Loop Insights CEO Rob Anson stated: “Loop Insights utilization of Artificial Intelligence and IoT technology was already turning heads in retail with our ability to deliver dynamic, personalized promotions in real-time. With ImagineAR’s immersive AR applications, we can create a whole new world of engagement that does not exist today. Together, our innovative solution unlocks engagement strategies that consumers simply have not previously experienced. This is the convergence of AI, IoT, and AR that technology companies have been promising the retail industry for years.”

THE COMBINED OFFERING AND MARKET OPPORTUNITY

ImagineAR allows its clients real-time engagement with their consumer using mobile augmented reality. Loop Insights enhances the AR solution with artificial intelligence to make the customer experience hyper-personalized promotions for the purpose of generating a higher average spend. Loop and ImagineAR will jointly introduce their platform to each other’s global client networks to increase reach and accelerate scalability. Revenues will be driven through onboarding and annual licensing fees, both companies will also benefit from monthly Software as a Service (SaaS) and managed service fees.

ImagineAR CEO Paul Silverrstieen added: “Both of our companies are already focused on the sports, entertainment and retail industries. ImagineAR’s platform solution captures fan and consumer attention with its immersive experiential AR activations. Now with Loop’s integration, we can offer highly personalized, dynamic targeted promotions to increase loyalty and consumer spend, as well as marketing attribution to create detailed fan loyalty profiles, for our shared global clients.”

Together, the companies plan on seizing huge market opportunities in AR and AI. According to Allied Market Research, in 2017, the global augmented and virtual reality market size was $11.35 billion and is now projected to reach $571.42 billion by 2025—growing at a CAGR of 63.3%. The global artificial intelligence market size was estimated at $39.9 billion in 2019 and is expected to reach 62.3 billion by the end of this year (2020) alone. The companies are set on capturing meaningful market share by merging their respective groundbreaking technologies, which are already achieving 3rd party validation.

About ImagineAR Inc.
ImagineAR is an augmented reality (AR) platform that enables businesses of any size to create and implement their own AR campaigns with no programming or technology experience. Every organization, from professional sports franchises to small retailers, can develop interactive AR campaigns that blend the real and digital worlds. Customers simply point their mobile device at logos, signs, buildings, products, landmarks, and more to instantly engage videos, information, advertisements, coupons, 3-D holograms, and any interactive content all hosted in the cloud and managed using a menu-driven portal.

About Loop Insights: Loop is a Vancouver-based technology company that provides transformative artificial intelligence services and IoT solutions to the brick and mortar retail industry to support its longevity in the face of a growing online consumer culture. At the core of its solution is the Fobi IoT technology, which has the unique ability to connect company-wide data with in-store transactional data in real time. This disruptive capability creates revenue-generating insights, which can be actioned through Loop’s automated personalized marketing platform to increase foot traffic, wallet share, loyalty and spend.

Forward-Looking Statements/Information:

This news release contains certain statements which constitute forward-looking statements or information. Such forward-looking statements are subject to numerous risks and uncertainties, some of which are beyond Loop’s control, including the impact of general economic conditions, industry conditions, and competition from other industry participants, stock market volatility and the ability to access sufficient capital from internal and external sources. Although Loop believes that the expectations in its forward-looking statements are reasonable, they are based on factors and assumptions concerning future events which may prove to be inaccurate. Those factors and assumptions are based upon currently available information. Such forward-looking statements are subject to known and unknown risks, uncertainties and other factors that could influence actual results or events and cause actual results or events to differ materially from those stated, anticipated or implied in the forward-looking statements. As such, readers are cautioned not to place undue reliance on the forward-looking statements, as no assurance can be provided as to future results, levels of activity or achievements. The forward-looking statements contained in this news release are made as of the date of this news release and, except as required by applicable law, Loop does not undertake any obligation to publicly update or to revise any of the included forward-looking statements, whether as a result of new information, future events or otherwise. The forward-looking statements contained in this document are expressly qualified by this cautionary statement. Trading in the securities of Loop should be considered highly speculative. There can be no assurance that Loop will be able to achieve all or any of its proposed objectives.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Tags: AR, augmented reality, CSE, stocks, tsx, tsx-v, virtual reality, VR
Posted in Featured, Imagine AR, Loop Insights Inc. | Comments Off on Loop Insights $MTRX.ca and ImagineAR $IP.ca $IPNFF Sign MOU To Integrate Artificial Intelligence and Augmented Reality #AR, Creating Real-Time Actionable Data For Brands To Hyper Target Consumers and Sports Fans

St-Georges Eco-Mining Corp. $SX $SX.ca $SXOOF Provides Lithium Processing Technology Update

Posted by AGORACOM-JC at 3:21 PM on Sunday, July 19th, 2020

provide additional information regarding the contracted pilot plant facilities of Carrefour innovation sur les materiaux de la MRC des Sources or “CIMMS” initially disclosed in a press release on July 10, 2020
The Company is also providing an update on its research and development process that is now fully reactivated following a slower development period in the last quarter

Montreal, July 19, 2020 – St-Georges Eco-Mining Corp. (CSE: SX) (OTC: SXOOF) (FSE: 85G1) is pleased to provide additional information regarding the contracted pilot plant facilities of Carrefour innovation sur les materiaux de la MRC des Sources or “CIMMS” initially disclosed in a press release on July 10, 2020. The Company is also providing an update on its research and development process that is now fully reactivated following a slower development period in the last quarter.

The pilot plant operations

The pilot plant being contracted is a “state of the art” newly-built facility owned and operated by CIMMS.

The agreement has an 18-month duration and can be extended. It marks the beginning of a new phase of testing in the development of the Company’s lithium processing technology.

CIMMS-contracted infrastructures and resources allow St-Georges Metallurgy to scale up instantly without the lag time usually experienced when research teams integrate new members and train on new equipment. CIMMS also contributes immediately to the Company’s bank of resources and expertise by making available experienced and highly respected lithium metallurgy researchers. The CIMMS-led team consists of:

Yu-Mei Han, Ph.D. Metallurgy, who is the technical director and was the process engineer during the start up of the Quebec lithium mine. She is very experienced in lithium pilot plant design and conception.

Denys Pinard, Chemist with nearly 40 years’ experience in hydrometallurgy. Denys was the 4^th person hired by Quebec Lithium, where he participated in the start up of their commercial plant. His expertise revolves around lithium extraction processes, spodumene decrepitation, sulfidation, lixiviation, purification, and carbonation.

Jonathan Viens, Operation supervisor of the CIMMS, Jonathan has experience in characterization and optimization of spodumene acidulation processes. He has worked on the realization of different projects, specifically on optimizing lithium recovery.

Sylvain Couture, Eng. Director of CIMMS, Sylvain accumulates decades of experience in industrial equipment conception. Over the years, he contributed to various R&D initiatives focusing on industrial reject alternative usage and was involved in the start up of various industrial plants.

Enrico Di Cesare, St-Georges Metallurgy’s President, commented: “(…)With the extent of the partners and the laboratories we now have integrated with our research initiatives, we have the flexibility and scalability to fulfill all our research needs (…) the infrastructure and experience that is available and the elimination of team integration and equipment learning curves should reduce the lag time between design and conception and real-life industrial testing significantly. (…) The current approach allows development and innovation in parallel or allows multiple technical teams to work in conjunction to achieve innovation or solutions as required. (…) The elimination of fixed costs, building and commissioning, and the level of control we now have on our development and testing costs allow us to take chances on concepts that would have been put aside before. We will continue to focus on Key Performance Indicators but have some flexibility to try outside the box thinking and more freedom to innovate (…)”

For pictures and description of the CIMMS facilities, please scroll down to the end of this press release

Lithium Processing Technology Advancements

Shareholders and stakeholders alike should remember that the Company was able to concentrate mechanically the lithium found in the clay in the material obtained from Nevada Lithium projects. Air classification resulted in the elimination of 55% of the gangue material with no lithium loss resulting in an increase of approximately 2.2 times the lithium content in the resulting material (See Press Release “Independent Review of Phase One Lithium in Clay R&D Completed”, July 24, 2019).

Additional concentration with Nitric and Citric acid allowed for the elimination of up to 96% of the material without loss of lithium. The resulting 4% having 99.9% of the lithium still present in the solution and being equivalent to a 25-fold increase of lithium concentration in the resulting solution.

Click Image To View Full Size

Fig. 1 St-Georges’ Hydrometallurgical Lithium Extraction Process Phases

Larger scale tests now take in account the moisture content of the material, often up to 17% moisture, that the clay sediment carries and which results in almost the same percentage of acid loss that cannot be recycled in the process and also, currently, of some lithium loss up to the same 17% when the leach solution is filtered.

A conceptual scenario using 44 tonnes of feeding material from a blend of lithium-in-clay type projects would result in 24 tonnes being discarded and 20 tonnes being sent to an acid bath of 180 tonnes of a proprietary mix of acid dominated by nitric acid.

In the tests conducted during Phase I and previously disclosed, the Company metallurgists were able to leach within less than an hour, over 99.9% of the lithium into solution, at atmospheric pressure and ambient temperature.

However, the lithium needs to be recuperated, and the Phase I report initially underlined a significant challenge for the process at the time. Fine materials like clays can retain much of the acid and lithium in filter cake losses. That can represent retention of humidity that is higher than other concentrates, up to 17% compared to a maximum of up to 8% in traditional lithium concentrates obtained from spodumene hosted in hard rock material. The Company’s R&D efforts are now focused on further concentration and the reduction of acid losses in the residues.

This phenomenon seems to be universal to all lithium-in-clay projects across the industry and is not a specific situation. It impacts the recuperation grade and cannot be overlooked. Optimizing the purification steps and minimizing chemical losses will continue to be the priority along with minimizing energy requirements. The intent is also to be able to show value-added by-products such as fertilizer and start working with the industry to optimize chemistry to meet clients’ needs and improve value.

This led to an interesting discovery by the metallurgical team. A new approach was introduced in the conception of the Phase II processing technology applied to this type of material. The Company is now ready to conduct scaling tests with a proprietary adaptation of resin balls that will allow the recuperation of the lithium in the leach solution without filtration. The Company believes that this will significantly reduce the loss due to the moisture content. Tests need to be conducted on a large scale to test the potential recuperation improvements as well as the loss of acid that would remain in the acid leach containers and be recycled to process more material. It is important to note that the lithium loss due to moisture in the filtration press ends up in the mining residue without creating important challenges. However, the acid rejected constitutes a more important issue as it needs to be neutralized, increasing infrastructure, neutralization material, and workforce costs that, even if it is not estimated yet, are guaranteed to be significant. The ability to scale the solution recently discovered is then paramount and constitutes an important and positive development.

Click Image To View Full Size

ON BEHALF OF THE BOARD OF DIRECTORS

“Vilhjalmur T. Vilhjalmsson”

VILHJALMUR THOR VILHJALMSSON

President & CEO

About Carrefour d’innovation sur les materiaux de la MRC des Sources (CIMMS)

CIMMS is a publicly funded research and development corporation located in Asbestos, Quebec. It is supported by numerous local and regional organizations, along with the provincial and federal governments. CIMMS develops and carries out technological innovation projects specifically related to the industrial, mining/metallurgy and innovative materials sectors.

About St-Georges Metallurgy Corp.

Created to manage all metallurgical research and development, joint ventures and partnerships, and hold all mineral processing technology intellectual property and patents. The Corporation is a wholly-owned subsidiary of St-Georges Eco-Mining Corp.

About St-Georges Eco-Mining Corp.

St-Georges is developing new technologies to solve some of the most common environmental problems in the mining industry. The Company controls all the active mineral tenures in Iceland. It also explores for nickel on the Julie Nickel Project & the Manicouagan Palladium Project on Quebec’s North Shore and for lithium and rare metals in Northern Quebec and in the Abitibi region. Headquartered in Montreal, St-Georges’ stock is listed on the CSE under the symbol SX, on the US OTC under the Symbol SXOOF and on the Frankfurt Stock Exchange under the symbol 85G1

The Canadian Securities Exchange (CSE) has not reviewed and does not accept responsibility for the adequacy or the accuracy of the contents of this release.

Tags: CSE, investing, small cap, stocks, tsx, tsx-v
Posted in All Recent Posts | Comments Off on St-Georges Eco-Mining Corp. $SX $SX.ca $SXOOF Provides Lithium Processing Technology Update

Datametrex $DM.ca Appoints New Chief Financial Officer

Posted by AGORACOM-JC at 1:46 PM on Friday, July 17th, 2020

Announced the appointment of Andrea Yuan, BA, CPA, CGA as new Chief Financial Officer
Prior to joining Datametrex, Ms. Yuan was Chief Financial Officer for several public companies listed on the TSX Venture Exchange. She and has been involved in several private placements, prospectus filings, flow-through financings, and corporate audits. Andrea is fluent in both English and Mandarin (oral and written).

TORONTO, July 17, 2020 – Datametrex AI Limited (“Datametrex” or the “Company”) (TSXV: DM, FSE: D4G, OTC: DTMXF) is pleased to announce the appointment of Andrea Yuan, BA, CPA, CGA as new Chief Financial Officer (“CFO”).

This new addition to the Company’s executive leadership team brings with her nearly 26 years of financial experience in accounting and financial control with a combination of private and public companies in a variety of industries including cannabis, resource, and financial services. Andrea Yuan will work to ensure Datametrex’s financial health through strategic planning and management of the company’s finances.

Prior to joining Datametrex, Ms. Yuan was Chief Financial Officer for several public companies listed on the TSX Venture Exchange. She and has been involved in several private placements, prospectus filings, flow-through financings, and corporate audits. Andrea is fluent in both English and Mandarin (oral and written).

“I am thrilled to join Datametrex and this impressive leadership team with a history of growing great companies,” said Andrea Yuan. “Datametrex’s newly announced Health Security with selling Covid-19 test kit is well positioned for success, and I am happy to be a part of this journey.”

Ms. Yuan is a Certified General Accountant in British Columbia and a Certified Public Accountant in New Hampshire. She obtained her Bachelor of Economics from Shanghai University of Finance and Economics in 1994. Ms. Yuan started her career as an internal auditor and then as team head of the internal audit department at the Bank of China’s Shanghai Pudong branch in China from 1994 through to 1999. After arriving in Canada in spring of 1999, Andrea worked as an accountant at a small accounting firm while she worked towards her CGA designation.

Andrea moved to Davidson and Company LLP, Chartered Accountants, in 2004 where she worked in the firm’s audit group. From November 2006 until 2009, Andrea was employed as an audit manager at Davidson. From 2009 until October 2011, Ms. Yuan was employed as an audit principal at Davidson. In addition to overseeing a variety of Canadian public company audit files, she was also responsible for conducting the audits of various foreign public companies including Chinese and Korean companies.

“On behalf of the executive team and our Board of Directors, I would like to thank Steve Kang for his dedication and hard work during his tenure as CFO. I wish Steve nothing but success in his future endeavours. The appointment of Ms. Yuan as the Company’s new CFO represents a great addition to our leadership team, and I look forward to working with Andrea as we move the Company forward,” said Marshall Gunter, CEO of the Company.

Steve Kang, the current CFO of the Company, has resigned from his position and will stay on for the next several weeks to support Datametrex during the transition of the financial leadership.

About Datametrex

Datametrex AI Limited is a technology focused company with exposure to Artificial Intelligence and Machine Learning through its wholly owned subsidiary, Nexalogy (www.nexalogy.com). Datametrex’s mission is to provide tools that support companies in fulfilling their operational goals, including Health and Safety, with predictive and preventive technologies. By working with companies to set a new standard of protocols through Artificial Intelligence and health diagnostics, the Company provides progressive solutions to support the supply chain. Additional information on Datametrex is available at www.datametrex.com

For further information, please contact:

Marshall Gunter – CEO
Phone: (514) 295-2300
Email: [email protected]

Neither the TSX Venture Exchange nor it’s Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Forward-Looking Statements

This news release contains “forward-looking information” within the meaning of applicable securities laws. All statements contained herein that are not clearly historical in nature may constitute forward-looking information. In some cases, forward-looking information can be identified by words or phrases such as “may”, “will”, “expect”, “likely”, “should”, “would”, “plan”, “anticipate”, “intend”, “potential”, “proposed”, “estimate”, “believe” or the negative of these terms, or other similar words, expressions and grammatical variations thereof, or statements that certain events or conditions “may” or “will” happen, or by discussions of strategy. Readers are cautioned to consider these and other factors, uncertainties and potential events carefully and not to put undue reliance on forward-looking information. The forward-looking information contained herein is made as of the date of this press release and is based on the beliefs, estimates, expectations and opinions of management on the date such forward-looking information is made. The Company undertakes no obligation to update or revise any forward-looking information, whether as a result of new information, estimates or opinions, future events or results or otherwise or to explain any material difference between subsequent actual events and such forward-looking information, except as required by applicable law.

Tags: AI, bot, covid19, CSE, datametrex, investments, small cap, tsx, tsx-v
Posted in Datametrex AI Limited | Comments Off on Datametrex $DM.ca Appoints New Chief Financial Officer

Loop Insights $MTRX.ca Announces International Contact Tracing Solution Update

Posted by AGORACOM-JC at 7:22 AM on Friday, July 17th, 2020

Announced that it has accelerated conversations for the implementation of its Covid-19 contact tracing solution with government officials, and live event and stadium operators, in North America, Australia, Indonesia, and the U.K., since its launch in June 2020.
Loop’s goal is to leverage this frictionless implementation process to gain government and public sector endorsement at all levels

VANCOUVER, BC, July 17, 2020 – Loop Insights Inc. (TSX.V: MTRX) (the “Company” or “Loop”)—provider of transformative artificial intelligence (“AI”) Internet of Things (“IoT”) solutions—announced that it has accelerated conversations for the implementation of its Covid-19 contact tracing solution with government officials, and live event and stadium operators, in North America, Australia, Indonesia, and the U.K., since its launch in June 2020.

Loop CEO Rob Anson stated: “Receiving this level of interest across verticals and geographical borders is a true testament to Loop’s unique IoT connectivity capabilities. Our core technology has always been built on automation, simplicity and usability. To be able to support the health, safety, and economic recovery of communities is incredibly motivating. Our opportunity to expand Loop’s global reach has never been greater.”

The coronavirus has had a devastating effect on the health and economies of 188 nations. Government officials and business owners are aware that a second wave is coming, and to prepare, they need proper protocols and mandates in place. Loop’s key to success stems from an ability to seamlessly integrate and enhance businesses’ existing solutions. With its SIM-enabled connectivity, and compatibility with up to forty languages, Loop’s contact tracing platform supports fast, scalable deployment anywhere in the world.

Loop’s goal is to leverage this frictionless implementation process to gain government and public sector endorsement at all levels. For government contracts, the Company will gain revenue from onboarding fees per location, an annual software licensing fee with managed service, and ongoing revenue from active user fees. For venue operators, revenue stems from onboarding fees, monthly Software as a Service (SaaS) fees, and ongoing active user fees.

Loop COO Gavin Lee added: “Loop strongly supports the continuation of physical distancing and its implementation in business operations. We understand the need to kickstart economies, but in order to instill confidence back into sports venue and other hospitality experiences, systems must be in place to protect both staff and customers.”

Combining Loop’s IoT and artificial intelligence capabilities with wallet pass technology, creates a digital Covid-19 Contact Card (stored in their Apple or Google wallet). Users tap their mobile device to check in. Check-ins are tracked based on time and location; and if an outbreak is recorded, the platform can provide real-time notifications to an unlimited number of users. The Company’s automated solution is contactless, fast, accurate and scalable—and for those reasons, it is well positioned for global scale.

Forward-Looking Statements/Information:

Tags: AI, covid19, Covid19 tracing, stocks, tsx, tsx-v
Posted in Loop Insights Inc. | Comments Off on Loop Insights $MTRX.ca Announces International Contact Tracing Solution Update

Empower Clinics $CBDT.ca Announces Closing of Private Placement Increased Demand for COVID-19 Testing and Are on Pace for Record July Patient Visits $WEED.ca $CGC $ACB $APH $CRON.ca $OGI.ca

Posted by AGORACOM-JC at 1:29 PM on Thursday, July 16th, 2020

Closes private placement of $720,866.00 to support the Company growth plan
Continues to meet increased demand for COVID-19 testing in Arizona clinics, along with supporting record patient demand in July 2020

VANCOUVER, BC / July 16, 2020 / EMPOWER CLINICS INC. (CSE:CBDT)(Frankfurt:8EC)(OTCQB:EPWCF) (“Empower” or the “Company“), a life sciences company, is pleased to announce the closing of its non-brokered private placement of an aggregate of 14,417,334 units of the Company (each, a “Unit“) at a price of $0.05 per Unit for gross proceeds of $720,866.00 (the “Offering“).

The proceeds of the Offering are expected to be used by the Company for general working capital and corporate purposes and to support the launch if it’s previously announced psychedelics division Dosed Wellness Ltd. www.dosedwellness.com

The Company also continues to see strong demand for COVID-19 testing supported by an expansion to five-day per week testing schedule in Phoenix, AZ clinics. In addition, Sun Valley Health has added ten (10) new hires and (4) internal management promotions in the past 30 days to manage the increased volumes of patients, that are anticipated to reach record levels in July 2020.

“Our clinic team continue to provide exemplary support and care for patients, in a safe and compassionate manner,” said Steven McAuley, Chairman & CEO. “Successfully accessing the capital markets to support growth allows the Company to advance its ongoing plan of providing diversified health & wellness services and positioning us to become a long-term market leader.”

Each Unit is comprised of one Share and one Warrant, with each Warrant exercisable into one Warrant Share at an exercise price of $0.12 per Warrant Share for a period of two years following the Closing.

The Units, and the underlying Shares, Warrants and Warrant Shares (collectively, the “Securities“), are subject to restrictions on resale under applicable Canadian securities laws for a period of four months and one day from the closing of the Offerings. None of the Securities have been or will be registered under the United States Securities Act of 1933, as amended, and may not be offered or sold in the United States absent registration or an applicable exemption from the registration requirements. This news release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of the securities, in any jurisdiction in which such offer, solicitation or sale would require registration or otherwise be unlawful.

ABOUT EMPOWER

Empower is a vertically integrated health & wellness company with a network of corporate and franchised health & wellness clinics in the U.S. The Company is focused on helping patients improve and protect their health, through innovative physician recommended treatment options. The Company has launched Dosed Wellness Ltd. to connect its significant data, to the potential of the efficacy of alternative treatment options related to hemp-derived cannabidiol (CBD) therapies, psilocybin and other psychedelic plant-based treatment options.

ON BEHALF OF THE BOARD OF DIRECTORS:

Steven McAuley
Chief Executive Officer

Investors: Dustin Klein
Director
dustin@svmmjcc,com
720-352-1398

Investors: Steven McAuley
CEO
[email protected]
604-789-2146

For French inquiries: Remy Scalabrini, Maricom Inc., E: [email protected], T: (888) 585-MARI

DISCLAIMER FOR FORWARD-LOOKING STATEMENTS

This news release contains certain “forward-looking statements” or “forward-looking information” (collectively “forward looking statements”) within the meaning of applicable Canadian securities laws. All statements, other than statements of historical fact, are forward-looking statements and are based on expectations, estimates and projections as at the date of this news release. Forward-looking statements can frequently be identified by words such as “plans”, “continues”, “expects”, “projects”, “intends”, “believes”, “anticipates”, “estimates”, “may”, “will”, “potential”, “proposed” and other similar words, or information that certain events or conditions “may” or “will” occur. Forward-looking statements in this news release include statements regarding; the Company’s intention to open a hemp-based CBD extraction facility, the expected benefits to the Company and its shareholders as a result of the proposed acquisitions and partnerships; the effectiveness of the extraction technology; the expected benefits for Empower’s patient base and customers; the benefits of CBD based products; the effect of the approval of the Farm Bill; the growth of the Company’s patient list and that the Company will be positioned to be a market-leading service provider for complex patient requirements in 2019 and beyond. Such statements are only projections, are based on assumptions known to management at this time, and are subject to risks and uncertainties that may cause actual results, performance or developments to differ materially from those contained in the forward-looking statements, including; that the Company may not open a hemp-based CBD extraction facility; that legislative changes may have an adverse effect on the Company’s business and product development; that the Company may not be able to obtain adequate financing to pursue its business plan; general business, economic, competitive, political and social uncertainties; failure to obtain any necessary approvals in connection with the proposed acquisitions and partnerships; and other factors beyond the Company’s control. No assurance can be given that any of the events anticipated by the forward-looking statements will occur or, if they do occur, what benefits the Company will obtain from them. Readers are cautioned not to place undue reliance on the forward-looking statements in this release, which are qualified in their entirety by these cautionary statements. The Company is under no obligation, and expressly disclaims any intention or obligation, to update or revise any forward-looking statements in this release, whether as a result of new information, future events or otherwise, except as expressly required by applicable laws.

Tags: CBD, CSE, Dosed Movie, Dosed Wellness, Hemp, tsx, tsx-v
Posted in All Recent Posts, Empower Clinics Inc., Featured | Comments Off on Empower Clinics $CBDT.ca Announces Closing of Private Placement Increased Demand for COVID-19 Testing and Are on Pace for Record July Patient Visits $WEED.ca $CGC $ACB $APH $CRON.ca $OGI.ca

TransCanna $TCAN.ca Commences “Phase 1” Construction and Roll-Out of Commercial Activities at Flagship Daly Facility $CGC $ACB $APH $CRON.ca $OGI.ca

Posted by AGORACOM-JC at 7:01 AM on Thursday, July 16th, 2020

Begun preparations for the commercial launch of distribution activities at its flagship 196,000 square foot Daly Avenue Facility in Modesto California
Goal of Phase 1 is to focus on expansion and ramp-up of the companies’ distribution activities
Revised design of Phase 1 of the Daly Distribution build-out increases capacity by 16,000 square feet, allowing the Company to expand this core business unit to service escalating demand from customers

Vancouver, British Columbia–(July 16, 2020) – TransCanna Holdings Inc. (CSE: TCAN) (XETR: TH8) (“TransCanna” or the “Company”) is pleased to announce that with the recent state-wide final license approval, today its wholly-owned subsidiary, Lyfted Farms, Inc. (“Lyfted”), has begun preparations for the commercial launch of distribution activities at its flagship 196,000 square foot Daly Avenue Facility in Modesto California.

The goal of Phase 1 is to focus on expansion and ramp-up of the companies’ distribution activities. The revised design of Phase 1 of the Daly Distribution build-out increases capacity by 16,000 square feet, allowing the Company to expand this core business unit to service escalating demand from customers.

“After many months of planning and preparation, our team is thrilled to begin operations inside of Daly,” said CEO Bob Blink. “We look forward to rewarding our investors’ patience with this initial phase and present the true potential we believe The Daly Building has to offer. As early as Q4 2020, we expect to see an incremental increase in revenue from Distribution activities in the vicinity of $6,000,000 CDN per quarter. When combined with existing revenues, our target run-rate by our fiscal year-end should exceed previous projections and be in the neighborhood of $36,000,000 CDN.”

Lyfted Farms has accepted a contract with Bay Alarm Company to install a state of the art, integrated security system in preparation for commercial activity at the Daly facility. Pre-site preparations are underway, and system completion is expected by August 15, 2020.

Additionally, the facility’s triple-redundancy heating, ventilation, and air conditioning “HVAC,” sub-forty-degree Fahrenheit freezer, and distribution area systems have been activated for pre-cooling and calibration within the areas of operation. Employee technician training has started on the Company’s high speed automated packaging systems, combining WeighPack Swifty Baggers and Combiscale 14-head rotary scales to provide high-efficiency and precision filling, which reduce labor and material costs to industry-leading levels.

Packaging and support materials began arriving this week into the Daly distribution center with completion of the Phase 1 Distribution build-out expected by September 15, 2020.

About TransCanna Holdings Inc.

TransCanna Holdings Inc. is a California based, Canadian listed company building Cannabis-focused brands for the California lifestyle, through its wholly-owned California subsidiaries.

For further information, please visit the Company’s website at www.transcanna.com or email the Company at [email protected].

On behalf of the Board,

Bob Blink, CEO
604-349-3011

Neither the Canadian Securities Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release.

Forward-Looking Statements

This release includes certain statements and information that may constitute forward-looking information within the meaning of applicable Canadian securities laws or forward-looking statements within the meaning of the United States Private Securities Litigation Reform Act of 1995. Forward-looking statements relate to future events or future performance and reflect the expectations or beliefs regarding future events of management of the Company. Generally, forward-looking statements and information can be identified by the use of forward-looking terminology such as “intends” or “anticipates”, or variations of such words and phrases or statements that certain actions, events or results “may”, “could”, “should”, “would” or “occur”. This information and these statements, referred to herein as “forward‐looking statements”, are not historical facts, are made as of the date of this news release and include without limitation estimates and forecasts and statements as to management’s expectations for growth and the commencement of operations of the Company’s Daly facility.

The forward-looking information in this press release is based upon certain assumptions that management considers reasonable in the circumstances, including that operations will commence at the Company’s Daly facility in Modesto, California as and when expected.

These forward‐looking statements involve numerous known and unknown risks, uncertainties and other factors that may cause actual results, events or developments to be materially from any future results, events or developments expressed or implied by such forward-looking statements. Risks and uncertainties associated with the forward looking information in this news release include, among others, dependence on obtaining and maintaining regulatory approvals, including state, local or other licenses and any inability to obtain all necessary governmental approvals licenses and permits to complete upgrades to its Daly facility in a timely manner; engaging in activities which currently are illegal under U.S. federal law and the uncertainty of existing protection from U.S. federal or other prosecution; regulatory or political change such as changes in applicable laws and regulations, including U.S. state-law legalization, particularly in California, due to inconsistent public opinion, perception of the medical-use and adult-use marijuana industry, bureaucratic delays or inefficiencies or any other reasons; any other factors or developments which may hinder market growth;; reliance on management; and the effect of capital market conditions and other factors (including those related to the COVID-19 pandemic) on capital availability; competition, including from more established or better financed competitors; and the need to secure and maintain corporate alliances and partnerships, including with customers and suppliers.

Although management of the Company has attempted to identify important factors that could cause actual results to differ materially from those contained in forward-looking statements or forward-looking information, there may be other factors that cause results not to be as anticipated, estimated or intended. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements and forward-looking information. The Company does not undertake to update any forward-looking statement, forward-looking information or financial out-look, except in accordance with applicable securities laws.

Tags: california cannabis, Cannabis, CBD, CSE, Hemp, Marijuana, small cap, small cap stocks, tsx
Posted in Featured, TransCanna Holdings Inc. | Comments Off on TransCanna $TCAN.ca Commences “Phase 1” Construction and Roll-Out of Commercial Activities at Flagship Daly Facility $CGC $ACB $APH $CRON.ca $OGI.ca

Avicanna $AVCN.ca Announces Participation in a Medical #Cannabis Real-World Evidence Research Study Led by the University Health Network in Partnership with Medical Cannabis by #Shoppers™ using its Rho Phyto™ Advanced Medical Cannabis Formulary of Products

Posted by AGORACOM-JC at 8:10 AM on Wednesday, July 15th, 2020

http://www.smallcapepicenter.com/Avicana%20square%20logo.jpg

Rho Phyto portfolio contains a full formulary of products including oil drops, sublingual sprays, capsules, and topicals that have controlled dosing, enhanced absorption and stability studies supported by pre-clinical data which will be available exclusively on the Medical Cannabis by Shoppers™ online portal by the end of July 2020.

First-of-its-kind Canadian study is led by Dr. Hance Clarke, Director of Pain Services at Toronto General Hospital, and will examine the efficacy of a select group of medical cannabis products including Avicanna’s Rho Phyto line of products on patient reported outcomes of pain, sleep and anxiety.

This specific study is aligned and in parallel with Avicanna’s comprehensive clinical program of other real-world evidence studies involving the Rho Phyto products and clinical trials on its pharmaceutical pipeline with world-class, Toronto-based medical institutions.

TORONTO, July 15, 2020 – Avicanna Inc. (“Avicanna” or the “Company“) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN), a biopharmaceutical company focused on the development, manufacturing and commercialization of plant-derived cannabinoid-based products is pleased to announce that its Rho Phyto™ product line of advanced medical cannabis products will be the subject of a Medical Cannabis Real-World Evidence study (“MC-RWE Study“) led by Dr. Hance Clarke of the University Health Network (“UHN“) in Toronto, Canada. The Rho Phyto products were developed in accordance with the recent Health Canada Cannabis 2.0 regulations that allow for more advanced, higher quality, medical cannabis product offerings. These products have been tested for prolonged stability, enhanced absorption, controlled delivery and other properties, in collaboration with Dr. Christine Allen’s research group at the Leslie Dan Faculty of Pharmacy, University of Toronto.

The Rho Phyto medical cannabis product line is a full formulary that includes sublingual sprays, oil drops, capsules, and topicals of various cannabinoid ratios, namely THC and CBD. By offering a variety of delivery systems, the medical community has the possibility to select the appropriate Rho Phyto product to suit a range of medical conditions such as pain relief, which may require either a fast onset of action or prolonged duration of effect over the course of treatment. The products are manufactured under good manufacturing practice (“GMP“) in partnership with MediPharm Labs Inc. to ensure batch-to-batch consistency and high-quality products. The manufacture of the Rho Phyto products in accordance with GMP standard allows for data derived from this MC-RWE Study to provide early insights into Avicanna’s ongoing and future directions of pharmaceutical development. Avicanna remains committed to patient safety and product consistency which is why all products subject to the MC-RWE Study are tested by Sigma Analytical and tracked by TruTrace Blockchain Technologies.

Dr. Justin Grant, Avicanna’s Executive Vice President of Scientific Affairs commented, “After 3 years of collaborating with world-class Toronto-based researchers and clinicians including those at the University of Toronto and UHN, we are excited to offer the most consistent formulary of advanced medical cannabis products to prescribers and principal investigators, including Dr. Clarke, to further demonstrate the potential therapeutic efficacy of cannabinoids.”

Avicanna’s Rho Phyto products will be exclusively available to patients through the Medical Cannabis by Shoppers online portal in addition to UHN clinicians through the MC-RWE Study by the end of July 2020. Additionally, Avicanna and Medical Cannabis by Shoppers are co-hosting a medical symposium in line with the launch of the Rho Phyto product line entitled, “MEDICAL CANNABIS 2.0: Advancements in Cannabinoid Research, Product Offerings and Patient Access“. The symposium will be held on a virtual platform on July 21, 2020 and will include Dr Clarke’s presentation “Real World Evidence and The Future of Medical Cannabis / Cannabinoid medicine for Pain Management” that will provide further insights on the MC-RWE Study. For registration and more information please visit (https://www.avicanna.com/symposium/).

About Avicanna Inc.

Avicanna is an Ontario, Canada based corporation focused on the development, manufacturing, and commercialization of plant-derived cannabinoid-based products through its two main business segments, cultivation and research and development.

Avicanna’s two majority-owned subsidiaries, Sativa Nativa S.A.S. and Santa Marta Golden Hemp S.A.S., both located in Santa Marta, Colombia are the base for Avicanna’s cultivation activities. These two companies are licensed to cultivate and process cannabis for the production of cannabis extracts and purified cannabinoids including cannabidiol (CBD) and tetrahydrocannabinol (THC).

Avicanna’s research and development business is primarily conducted out of Canada at its headquarters in the Johnson & Johnson Innovation Centre, JLABS @ Toronto. Avicanna’s scientific team develops products, and Avicanna has also engaged the services of researchers at the Leslie Dan Faculty of Pharmacy at the University of Toronto for the purpose of optimizing and improving upon its products.

Avicanna’s research and development and cultivation activities are focused on the development of its key products, including plant-derived cannabinoid pharmaceuticals, phyto-therapeutics, derma-cosmetics, and Extracts (defined as plant-derived cannabinoid extracts and purified cannabinoids, including distillates and isolates), with a goal of eventually having these products manufactured and distributed through various markets.

Stay Connected

For more information about Avicanna, visit www.avicanna.com, call 1-647-243-5283, or contact Setu Purohit, President by email [email protected].

Cautionary Note Regarding Forward-Looking Information and Statements

This news release contains “forward-looking information” within the meaning of applicable securities laws. Forward-looking information contained in this press release may be identified by the use of words such as, “may”, “would”, “could”, “will”, “likely”, “expect”, “anticipate”, “believe, “intend”, “plan”, “forecast”, “project”, “estimate”, “outlook” and other similar expressions, and includes statements with respect to the Rho Phyto products benefiting patients managing a range of medical conditions, the data derived from the MC-RWE Study providing the Company with early insights into Avicanna’s ongoing and future directions of pharmaceutical development, and the Rho Phyto products being available to patients through the Medical Cannabis by Shoppers online portal and UHN clinicians by end of July 2020. Forward-looking information is not a guarantee of future performance and is based upon a number of estimates and assumptions of management in light of management’s experience and perception of trends, current conditions and expected developments, as well as other factors relevant in the circumstances, including assumptions in respect of current and future market conditions, the current and future regulatory environment; and the availability of licenses, approvals and permits.

Although the Company believes that the expectations and assumptions on which such forward-looking information is based are reasonable, undue reliance should not be placed on the forward-looking information because the Company can give no assurance that they will prove to be correct. Actual results and developments may differ materially from those contemplated by these statements. Forward-looking information is subject to a variety of risks and uncertainties that could cause actual events or results to differ materially from those projected in the forward-looking information. Such risks and uncertainties include, but are not limited to current and future market conditions, including the market price of the common shares of the Company, and the risk factors set out in the Company’s annual information form dated April 15, 2020, filed with the Canadian securities regulators and available under the Company’s profile on SEDAR at www.sedar.com.

The statements in this press release are made as of the date of this release. The Company disclaims any intent or obligation to update any forward-looking information, whether as a result of new information, future events or results or otherwise, other than as required by applicable securities laws.

SOURCE Avicanna Inc.

Tags: cannabinoids, CSE, Marijuana, Medical Cannabis by Shoppers, Rho Phyto, stocks, tsx, tsx-v
Posted in Avicanna Inc., Featured | Comments Off on Avicanna $AVCN.ca Announces Participation in a Medical #Cannabis Real-World Evidence Research Study Led by the University Health Network in Partnership with Medical Cannabis by #Shoppers™ using its Rho Phyto™ Advanced Medical Cannabis Formulary of Products

Hollister Biosciences $HOLL.ca Provides Update on Q2 2020, Generated Record Quarterly Revenue of CDN$ 11.5 Million and Announces Distribution License Renewal $WEED.ca $CGC $ACB $APH $CRON.ca $OGI.ca $FAF.ca

Posted by AGORACOM-JC at 8:05 PM on Tuesday, July 14th, 2020

Generated record quarterly revenue of CDN$ 11.5 million,
CDN$ 1.375 million in EBITDA
Bureau of Cannabis Control officially renewed its cannabis distribution license for the next year through August 2021

VANCOUVER, BC, July 14, 2020 – Hollister Biosciences Inc. (CSE: HOLL) (OTC: HSTRF) (FRANKFURT: HOB) (the “Company“, “Hollister Cannabis Co.” or “Hollister“) a diversified cannabis branding company with products in over 230 dispensaries throughout California, and over 80 dispensaries throughout Arizona, is pleased to provide an update on its Q2, 2020 performance as well as announce that the Bureau of Cannabis Control (“BCC“) officially renewed its cannabis distribution license for the next year through August 2021.

Q2 2020 Update

For the period beginning April 1st, 2020 and ending June 30th, 2020, Hollister reports that it generated record quarterly revenue of CDN$ 11.5 million and CDN$ 1.375 million in EBITDA from its product line of pre-rolls, concentrates, distillates, solvent-free bubble hash, pre-packaged flower, tinctures and vape products. The Company cautions that revenue and EBITDA figures have not yet been audited and are based on reports prepared by management.

“We are very pleased with our revenue growth year to date. Sales of cannabis related products have proven to be resilient throughout the COVID-19 pandemic. We hope to continue to deliver strong results as the year progresses” stated Carl Saling, CEO.

About the BCC

The Bureau of Cannabis Control is the lead agency in regulating commercial cannabis licenses for medical and adult-use cannabis in California. The BCC is responsible for licensing retailers, distributors, testing laboratories, microbusinesses, and temporary cannabis events. A distributor (Type 11) licensee is responsible for transporting cannabis goods between licensees, arranging for testing of cannabis goods, and conducting the quality assurance review of cannabis goods to ensure compliance with all packaging and labeling requirements. A licensed distributor may only distribute cannabis goods, cannabis accessories, and licensees’ branded merchandise or promotional materials.

“Our distribution license is a critical component to our California operation, and we are honored to have had our license renewed by the BCC” stated Carl Saling, CEO.

About Hollister Biosciences Inc.

Hollister Biosciences Inc. is a multi-state cannabis company with a vision to be the sought-after premium brand portfolio of innovative, high-quality cannabis & hemp products. Hollister uses a high margin model, controlling the whole process from manufacture to sales to distribution or seed to shelf. Products from Hollister Biosciences Inc. include HashBone, the brand’s premier artisanal hash-infused pre-roll, along with concentrates (shatter, budder, crumble), distillates, solvent-free bubble hash, pre-packaged flower, pre-rolls, tinctures, vape products, and full-spectrum high CBD pet tinctures. Hollister Cannabis Co. additionally offers white-labeling manufacturing of cannabis products. Our wholly-owned California subsidiary Hollister Cannabis Co is the 1st state and locally licensed cannabis company in the city of Hollister, CA birthplace of the “American Biker”.

Website: www.hollistercannabisco.com

The CSE, nor its regulation services provider, does not accept responsibility for the adequacy or accuracy of this release.

Forward-Looking Information: This news release includes certain statements that may be deemed “forward-looking statements”. The use of any of the words “anticipate”, “continue”, “estimate”, “expect”, “may”, “will”, “would”, “project”, “should”, “believe” and similar expressions are intended to identify forward-looking statements. Although the Company believes that the expectations and assumptions on which the forward-looking statements are based are reasonable, undue reliance should not be placed on the forward-looking statements because the Company can give no assurance that they will prove to be correct. Since forward-looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. These statements speak only as of the date of this News Release. Actual results could differ materially from those currently anticipated due to a number of factors and risks including various risk factors discussed in the Company’s disclosure documents which can be found under the Company’s profile on www.sedar.com

Tags: Cannabis, CBD, CSE, Hemp, small cap, tsx
Posted in Featured, Hollister Biosciences | Comments Off on Hollister Biosciences $HOLL.ca Provides Update on Q2 2020, Generated Record Quarterly Revenue of CDN$ 11.5 Million and Announces Distribution License Renewal $WEED.ca $CGC $ACB $APH $CRON.ca $OGI.ca $FAF.ca

Augmented reality #AR heads-up displays for cars are finally a real thing – SPONSOR: Imagine AR $IP.ca $IPNFF $SEV.ca $VST.ca $YDX.ca $NTAR.ca

Posted by AGORACOM-JC at 9:51 AM on Tuesday, July 14th, 2020

SPONSOR: Imagine AR Inc. (IP:CSE) (IPNFF:OTCQB) is an Augmented Reality platform that allows businesses to easily launch AR campaigns. Clients Include: NBA Sacramento Kings, Mall of America, AT&T Shape and The Basketball Hall of Fame. The company recently announced partnership with Engaged Nation, an award winning leader in digital engagement marketing for casinos in addition to a collaboration with Music Superstar Flo Rida Learn More.

http://www.smallcapepicenter.com/imagine%20ar%20squre.jpg

Augmented reality heads-up displays for cars are finally a real thing

Ready for the next level of displays? The augmented reality head-up display (AR-HUD) of the new #SClass provides loads of #augmentedreality content for #drivingassistance systems and navigation information. #MercedesBenz #MBUX pic.twitter.com/LwGqGJvRjB

By: Jonathan M. Gitlin

When Audi briefed Ars on its newest electric car, the part that most piqued our interest was the news that the Q4 e-tron Sportback will feature an augmented reality heads-up display. As we explained in that article, Audi didn’t feel like elaborating much on the new technology. Perhaps it wishes it had, as it’s going to be beaten to the punch by its deadly rival Mercedes-Benz. When the 2021 S-Class debuts in September, the brand’s flagship sedan will offer an AR HUD, among other tech upgrades.

The automaker has even been forthcoming with some technical info on this latest driver assist. It uses a digital mirror device from Texas Instruments—perhaps no surprise given that TI has been developing automotive AR tech for a while now. The DMD has a resolution of 1.3 megapixels (or megamirrors, to be strictly accurate) and projects onto a 10˚ horizontal, 5˚ vertical aperture HUD, with the image appearing 33 feet (10m) away. (Mercedes-Benz says it’s the equivalent of a 77-inch monitor.)

Unfortunately, Mercedes-Benz hasn’t shared any still images of the AR HUD in action, and there were only a few seconds of video in the b-roll that the company provided. But the automaker did helpfully tweet out a longer video this morning, which we’ve embedded below, as it really is the best way to see how the system works. (If the embedded tweet isn’t showing up for you, you can view it here.)

Ready for the next level of displays? The augmented reality head-up display (AR-HUD) of the new #SClass provides loads of #augmentedreality content for #drivingassistance systems and navigation information. #MercedesBenz #MBUX pic.twitter.com/LwGqGJvRjB
— Daimler AG (@Daimler) July 10, 2020

As you can see, it fuses various sensor inputs from the vehicle like the forward-looking radar as well as optical sensors to alert or inform the driver. That information could be the distance to a car you’re following, or markers delineating the edge of the road in low-light situations, or navigation help via directional arrows that work a bit like the optimal racing line overlay in games like Forza.

I’ll admit it: I’m excited that this tech is finally making its way into production and I’m eager to try it out, although some in the automotive UX world are not entirely convinced that a limited field-of-view HUD is the right way to implement this idea versus a full AR windshield.

That tech was considered unworkable a few years ago, and early practical demos of AR driver assists used goggles instead. But by CES in 2019 there were already static demos from companies like Saint-Gobain Sekurit and the aforementioned TI. A successful implementation will require restraint on the part of the UX designers, with AR elements being used sparingly to avoid information overload that could actually be even more distracting to drivers. But given that the problem of distracted driving is partly a problem of where a driver is looking, AR has the potential to save lives.

Source: https://arstechnica-com.cdn.ampproject.org/c/s/arstechnica.com/cars/2020/07/augmented-reality-heads-up-displays-for-cars-are-finally-a-real-thing/?amp=1

Tags: AR, augmented reality, CSE, small cap, stocks, tsx, tsx-v
Posted in Featured, Imagine AR | Comments Off on Augmented reality #AR heads-up displays for cars are finally a real thing – SPONSOR: Imagine AR $IP.ca $IPNFF $SEV.ca $VST.ca $YDX.ca $NTAR.ca

KABN’s $KABN.ca #Blockchain Technology to Support Liquid Avatar Collectible Custom Icons $MOS.ca $MOGO.ca $CTZ.ca $PTO.ca $PAY.ca

Posted by AGORACOM-JC at 9:13 AM on Tuesday, July 14th, 2020

This image has an empty alt attribute; its file name is image-3.png

Later this summer Liquid Avatar platform (www.liquidavatar.com), will begin to offer users a new type of Avatar experience through the Liquid Avatar Marketplace
Liquid Avatar users will be able to acquire custom-designed and limited availability icons from leading professional pop culture, comic book, fantasy, manga, and contemporary Artists complete with an innovative digital authentication solution that has been traditionally managed as an on-site, personnel and location-based process

TORONTO, ON / July 14, 2020 / KABN Systems NA Holdings Corp. (CSE:KABN) (the “Company” or “KABN” or “KABN North America“), a Canadian Fintech company that specializes in continuous online identity verification, management and monetization in Canada and the US, is pleased to announce that later this summer its Liquid Avatar platform (www.liquidavatar.com), will begin to offer users with a new type of Avatar experience through the Liquid Avatar Marketplace (“Marketplace”). Liquid Avatar users will be able to acquire custom-designed and limited availability icons from leading professional pop culture, comic book, fantasy, manga, and contemporary Artists complete with an innovative digital authentication solution that has been traditionally managed as an on-site, personnel and location-based process.

All Liquid Avatars acquired from the Marketplace will be supported with a unique Digital Certificate of Authenticity, allowing each custom icon to have its own Blockchain identifier that can be transferred from one user to another. This methodology created by the KABN Network and supported by Blockchain technologies, will allow users to buy, sell and trade custom avatars and record the transfer and ownership of these collectible icons. The Marketplace will charge a fee for the issuance, recording, and management of the Digital Certificate of Authenticity and the transfer of ownership of digitized assets.

“The creation and distribution of Digital Certificates of Authenticity featuring unique Blockchain technologies for custom Liquid Avatars is a key business strategy for KABN North America,” said RJ Reiser, Chief Business Development Officer. “Like hockey, baseball and basketball cards, other sports, comic books, movie props, and signed memorabilia, we believe that digitized assets will represent a viable way for online audiences to be part of the growing collector community.”

In addition, as part of the Liquid Avatar Creator Program, icons can be designed to represent different “skins” for a user’s verified persona, like a school, gaming, family, friends, and business/work profile. Recently, Liquid Avatar, in partnership with the NCFA (www.ncfacanada.org), released a custom event icon for FFCON20 – Rise (https://www.accesswire.com/viewarticle.aspx?id=596745). This process allows users, businesses, events, associations, and other groups to create unique icons for their verified online groups and share content and offers with known users.

The Liquid Avatar Marketplace has over 20 professional creators on board already and 10 engaged in the creation process. In addition to a growing list of free Liquid Avatars, the Marketplace will have the ability to showcase a catalog of approved custom avatars for sale. Additional items like t-Shirts, hoodies, and other items featuring certain Liquid Avatars will be available for sale. KABN North America will be presenting Liquid Avatar with Apex Comic Group at this year’s virtual Comic-con International @home program on Saturday, July 25, 2020 at 5 pm Pacific / 8 pm Eastern – https://comiccon2020.sched.com/event/d4zK/apex-comics-publishing-group-2020-2021-exclusive-previews

The Company welcomes the public to request an invitation to be an early adopter of Liquid Avatar and earn rewards at: https://liquidavatar.com/liquid-avatar-early-adopter/

“Liquid Avatar custom icons represent a potentially significant opportunity to create revenue for KABN North America,” said Ben Kessler, CEO. “Anyone who knows a Fortnite player or other gamer knows that players are always looking to acquire the latest cosmetic enhancement and along with sports, comic book, movie and fantasy collectors, we believe we are targeting the right audience for our custom and collectible Liquid Avatars.”

About KABN North America – www.kabnnaholdco.com

KABN Systems NA Holdings Corp. through its wholly-owned subsidiary KABN Systems North America Inc. focuses on the verification, management and monetization of digital identity, empowering users to control and benefit from its use of their online identity. KABN propriety technology suite includes 4 key products:

KABN ID is an Always On, biometric and blockchain based digital identity validation and verification platform allowing users to continuously and confidently prove themselves throughout the online community.

Liquid Avatar allows users to create high-quality digital icons representing their online personas. These icons, in conjunction with KABN ID, allows users to use Liquid Avatars to share public and permission-based private data when they want and with whom they want. www.liquidavatar.com

KABN Card is a Visa approved prepaid card program allowing users to manage both digital and fiat currencies, and earn cashback and other loyalty incentives. www.kabncard.com

KABN KASH is a cashback, loyalty and engagement program that powers the KABN revenue ecosystem.

KABN provides its products and services at no cost to consumers and generates revenues through permission-based partner programs. www.kabnkash.com

KABN Systems NA Holdings Corp. is publicly traded on the Canadian Securities Exchange under the symbol: KABN

For more information, please visit www.kabnnaholdco.com or www.kabnsystemsna.com

For further information, please contact:

Ben Kessler
Chief Executive Officer
647-725-7742 Ext. 700
[email protected]

The CSE has not reviewed and does not accept responsibility for the adequacy or accuracy of this release.

This news release does not constitute an offer to sell, or a solicitation of an offer to buy, any securities under the KABN Financing in the United States. The securities have not been and will not be registered under the United States Securities Act of 1933, as amended (the “U.S. Securities Act”) or any state securities laws and may not be offered or sold within the United States or to U.S. Persons unless registered under the U.S. Securities Act and applicable state securities laws or an exemption from such registration is available.

Forward-Looking Information and Statements

This press release contains certain “forward-looking information” within the meaning of applicable Canadian securities legislation and may also contain statements that may constitute “forward-looking statements” within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. Such forward-looking information and forward-looking statements are not representative of historical facts or information or current condition, but instead represent only the Company’s beliefs regarding future events, plans or objectives, many of which, by their nature, are inherently uncertain and outside of the Company’s control. Generally, such forward-looking information or forward-looking statements can be identified by the use of forward-looking terminology such as “plans”, “expects” or “does not expect”, “is expected”, “budget”, “scheduled”, “estimates”, “forecasts”, “intends”, “anticipates” or “does not anticipate”, or “believes”, or variations of such words and phrases or may contain statements that certain actions, events or results “may”, “could”, “would”, “might” or “will be taken”, “will continue”, “will occur” or “will be achieved”. The forward-looking information and forward-looking statements contained herein may include, but is not limited to, information concerning the ability of the Company to generate revenues, roll out new programs and to successfully achieve business objectives, and expectations for other economic, business, and/or competitive factors.

By identifying such information and statements in this manner, the Company is alerting the reader that such information and statements are subject to known and unknown risks, uncertainties and other factors that may cause the actual results, level of activity, performance or achievements of the Company to be materially different from those expressed or implied by such information and statements. In addition, in connection with the forward-looking information and forward-looking statements contained in this press release, the Company has made certain assumptions. Among the key factors that could cause actual results to differ materially from those projected in the forward-looking information and statements are the following: changes in general economic, business and political conditions, including changes in the financial markets; changes in applicable laws; compliance with extensive government regulation. Should one or more of these risks, uncertainties or other factors materialize, or should assumptions underlying the forward-looking information or statements prove incorrect, actual results may vary materially from those described herein as intended, planned, anticipated, believed, estimated or expected.

Although the Company believes that the assumptions and factors used in preparing, and the expectations contained in, the forward-looking information and statements are reasonable, undue reliance should not be placed on such information and statements, and no assurance or guarantee can be given that such forward-looking information and statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such information and statements. The forward-looking information and forward-looking statements contained in this press release are made as of the date of this press release, and the Company does not undertake to update any forward-looking information and/or forward-looking statements that are contained or referenced herein, except in accordance with applicable securities laws. All subsequent written and oral forward-looking information and statements attributable to the Company or persons acting on its behalf is expressly qualified in its entirety by this notice.

Tags: blockchain, canadian fintech, crypto, CSE, Liquid Avatars, tsx, tsx-v
Posted in Featured, KABN Systems NA Holdings Corp. | Comments Off on KABN’s $KABN.ca #Blockchain Technology to Support Liquid Avatar Collectible Custom Icons $MOS.ca $MOGO.ca $CTZ.ca $PTO.ca $PAY.ca

Posts Tagged ‘tsx’

Augmented reality heads-up displays for cars are finally a real thing

Categories